Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

References

• Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exp Ther 1992;260:275–85
   PubMed Web of Science ®Google Scholar
• Altman RA, Hochberg MC, Moskowitz RW, et al. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905–15
   PubMed Web of Science ®Google Scholar
• Simon LS, Lipman AG, Caudill-Slosberg M, et al. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis, 2nd edn. Glenview, IL: American Pain Society, 2002
   Google Scholar
• Katz WA. Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs 1996;52(Suppl 3):39–47
   PubMedGoogle Scholar
• Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004:CD003726
   Google Scholar
• Mattia C, Coluzzi F. Tramadol. Focus on musculoskeletal and neuropathic pain. Minerva Anestesiol 2005;71:565–84
   PubMedGoogle Scholar
• ULTRAM® (tramadol hydrochloride tablets) prescribing information. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., 2004
   Google Scholar
• ULTRAM® ER (tramadol HCl) Extended-Release Tablets prescribing information. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., 2006
   Google Scholar
• Lai JCK, Sista S, Eradiri O. The pharmacokinetics of novel once daily tramadol hydrochloride extended release tablets in healthy subjects [abstract]. AAPS PharmSci 2003;5:M1071
   Google Scholar
• Eradiri O, Sista S, Lai JCK, et al. Bioavailability of extended-release and immediate-release formulations of tramadol HCl [Abstract #126]. J Clin Pharmacol 2006;46
   Google Scholar
• Deschamps M, Band PR, Hislop TG, et al. The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine. J Pain Symptom Manage 1992;7:384–92
   PubMed Web of Science ®Google Scholar
• Gambling D, Hughes T, Martin G, et al. A comparison of Depodur, a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery. Anesth Analg 2005;100:1065–74
   PubMed Web of Science ®Google Scholar
• Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59–71
   PubMed Web of Science ®Google Scholar
• Gana TJ, Pascual MLG, Fleming RRB, et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006;22:1391–401
   PubMed Web of Science ®Google Scholar
• A study comparing the effectiveness and safety of extended-release tramadol versus placebo in the treatment of chronic low back pain. Available at: http://www.clinicaltrials.gov/ct/show/NCT00347724. Accessed June 6, 2007
   Google Scholar
• Haertzen CA. Addiction Research Center Inventory (ARCI): development of a general drug estimation scale. J Nerv Ment Dis 1965;141:300–7
   PubMed Web of Science ®Google Scholar
• Brady JV, Lukas SE, eds. Testing Drugs for Physical Dependence Potential and Abuse Liability: NIDA Research Monograph 52. Rockville, MD: National Institute on Drug Abuse, 1984
   Google Scholar
• Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589–94
   Google Scholar
• Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev 2006;3:CD005522
   Google Scholar
• Hollingshead J, Duhmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006;3: CD003726
   Google Scholar
• Moulin DE. Systemic drug treatment for chronic musculoskeletal pain. Clin J Pain 2001;17:S86–93
   PubMed Web of Science ®Google Scholar
• Whelton A. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease. Am J Cardiol 2006;97:3–9
   PubMed Web of Science ®Google Scholar
• Scheiman JM. Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases. Drugs 2006; 66(Suppl 1):15–21
   PubMedGoogle Scholar
• Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004;40:6–9
   Google Scholar
• Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and non steroidal antiinflammatory drugs. N Engl J Med 1994;331:1675–9
   Google Scholar
• Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17–32
   PubMed Web of Science ®Google Scholar
• Murthy BP, Skee DM, Danyluk AP, et al. Pharmacokinetic model and simulations of dose conversion from immediate- to extended-release tramadol. Curr Med Res Opin 2007;23:275–84
   PubMed Web of Science ®Google Scholar
• Hrachovec JB, Mora M. Reporting of 6-month vs. 12-month data in a clinical trial of celecoxib [letter]. JAMA 2001;286:2398
   Google Scholar
• Zacny JP. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology (Berl) 2003;165:146–56
   PubMed Web of Science ®Google Scholar
• Zacny JP, Gutierrez S. Characterizing the subjective, psycho-motor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl) 2003;170:242–54
   PubMed Web of Science ®Google Scholar
• Zacny JP, Hill JL, Black ML, et al. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther 1998;286:1197–207
   PubMed Web of Science ®Google Scholar
• Zacny JP, Conley K, Galinkin J. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther 1997;282:1187–97
   Google Scholar
• Zacny JP, Conley K, Marks S. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. J Pharmacol Exp Ther 1997;280:1159–69
   Google Scholar
• Cicero TJ, Inciardi JA, Adams EH, et al. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994–2004. Pharmacoepidemiol Drug Saf 2005;14:851–9
   PubMed Web of Science ®Google Scholar
• Senay EC, Adams EH, Geller A, et al. Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 2003;69:233–41
   PubMed Web of Science ®Google Scholar
• Farrar JT, Young JP, Jr., LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94: 149–58
   Google Scholar
• Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 2003;25:406–11
   Google Scholar
• Tubach F, Ravaud P, Baron G, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005;64:29–33
   PubMed Web of Science ®Google Scholar
• Kosinski M, Janagap C, Gajria K, et al. Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis. Curr Med Res Opin 2007;23:1615–26
   PubMed Web of Science ®Google Scholar
• Mullican WS, Lacy JR. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin Ther 2001;23:1429–45
   PubMed Web of Science ®Google Scholar
• Ruoff GE, Rosenthal N, Jordan D, et al. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003;25:1123–41
   PubMed Web of Science ®Google Scholar
• McQuay H, Edwards J. Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol Suppl 2003;28:19–22
   PubMedGoogle Scholar